CervoMed Inc. (CRVO) vs MIRA Pharmaceuticals, Inc. (MIRA)
A side-by-side comparison of CervoMed Inc. and MIRA Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CRVO
CervoMed Inc.
$3.20HealthcareDelayed quote: Oct 6, 2026, 11:49 AM EDT
MIRA
MIRA Pharmaceuticals, Inc.
$0.74HealthcareDelayed quote: Oct 6, 2026, 11:43 AM EDT
Total return — CRVO vs MIRA
growth of $100 · dividends reinvested · last 3yCRVO -34.8% (-13.3%/yr)MIRA -88.5% (-51.4%/yr)CRVO compounded faster over this window
Log scale — wide-divergence pair
CRVO MIRA
CRVO vs MIRA: by the numbers
- •MIRA is the larger company ($31M vs $30M market cap).
- •Both run net losses; MIRA's is the smaller (0.00% vs -9408.76% net margin).
Metrics side by side
Valuation
| Metric | CRVO | MIRA |
|---|---|---|
| P/S ratio | 91.85 | N/A |
| P/B ratio | 1.29 | 3.82 |
Profitability
| Metric | CRVO | MIRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -9408.76% | 0.00% |
| ROE | -132.18% | -116.14% |
| ROIC | -135.73% | -115.18% |
Growth (annualized)
| Metric | CRVO | MIRA |
|---|---|---|
| Total return CAGR (5Y) | -38.25% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.